Previous studies had suggested that treatment of an adult-onset ADPKD model with Alisertib resulted in exacerbation of cystic phenotypes32,33, an observation consistent with the increase in AURKA stability and AKT activation noted in vitro (Fig. 5f–i). The gene discussed is AURKA; the disease is autosomal dominant polycystic kidney disease.